| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/24/2008 | US20080096843 For crops; 3-(2,6-Dichlorophenyl)-4-[(3-pyridyl)hydroxymethyl]-5-trimethylsilylisoxazole for example |
| 04/24/2008 | US20080096841 Using analogs of Lipid A such as Eritoran to treat or prevent mucositis, allograft/graft rejection, arteriosclerosis, atherosclerosis, hepatitis, asthma, and inflammatory bowel disease |
| 04/24/2008 | US20080096839 DNA vector encoding the RNA molecules and synthesized siRNA molecules; gene expression and viral replication inhibition |
| 04/24/2008 | US20080096832 non-nucleoside HIV-1 reverse transcriptase inhibitor (NNRTI); co-administering cytochrome P450 inhibitor such as ritonavir to reduce metabolism of the NNRTI 5,11-Dihydro-11-ethyl-5-methyl-8- {2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepin-6-one, (BILR 355 ) by half |
| 04/24/2008 | US20080096831 Stabilized azithromycin composition |
| 04/24/2008 | US20080096829 Derivatives of erythromycin A and azithromycin having quinoline, [1,3]oxazino[5,4,3-ij]quinoline, or [1,4]oxazepino[2,3,4-ij]quinoline substituent; macrolide-resistant bacterial infections; Staphylococcus, Streptopococcus, Moraxella, Hemophilus, Enterococcus, Chlamydia, Mycoplasma, or Legionella |
| 04/24/2008 | US20080096806 Compositions and methods for inhibiting microbial adhesion |
| 04/24/2008 | US20080096263 Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus |
| 04/24/2008 | US20080095868 Use of fermented wheat-germ in the feeding and veterinary practice |
| 04/24/2008 | US20080095829 Antimicrobial composites, films, labelstocks and labels |
| 04/24/2008 | US20080095821 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
| 04/24/2008 | US20080095812 Systems providing antimicrobial activity to an environment |
| 04/24/2008 | US20080095804 Two-step immunization procedure against chlamydia infection |
| 04/24/2008 | US20080095801 Containing Ledum palustre (marsh tea or wild rosemary), in form of homeopathic dilution in inert carrier material and at least one secretion from a parasite, a sufferer of disease caused by parasites, or from an intermediate host, in form of homeopathic dilution in inert carrier; for ticks, mosquitoes |
| 04/24/2008 | US20080095800 Eliciting HCV-specific antibodies |
| 04/24/2008 | US20080095796 IBD virus TY2 strain or a passage strain of said viral strain allows for production of a vaccine that is efficacious to IBD variant viral strains that may have new properties not protectable by the conventional vaccines |
| 04/24/2008 | US20080095793 Expression vector comprising nucleotide sequences coding protein fusion for use in treatment and prevention of microorganismal infection |
| 04/24/2008 | US20080095791 Nucleotide sequences coding human immunodeficiency viral envelope protein fusion comprising epitopes from three viral variants for use in developing antibodies to prevent viral infection |
| 04/24/2008 | US20080095788 Vaccines |
| 04/24/2008 | US20080095778 Treatment Of Fungal Infections |
| 04/24/2008 | US20080095769 Monoclonal antibody secific to lymphocyte peripheral membrane protein for treating and preventing transplant rejection, blood, skin, autoimmune, allergic and diabetic disorders |
| 04/24/2008 | US20080095762 Glycoprotein compositions |
| 04/24/2008 | US20080095756 De-immunized antibiotic polypeptide for prevention and treatment of microbial infection |
| 04/24/2008 | US20080095742 Composition for Treating Virus Infection Disease Comprising Jab1 |
| 04/24/2008 | US20080095740 4-piperazine-4-piperidine-1-ketone derivatives; graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides |
| 04/24/2008 | US20080095717 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |
| 04/24/2008 | DE102007042009A1 Pharmaceutical formulation, useful e.g. to treat AIDS, gastrointestinal diseases and skin diseases and to inhibit formation of tumors, comprises violet Agave extract, preferably Tradescantia spathacea |
| 04/24/2008 | DE102007036342A1 Foot towel comprises a base member with an active material surface, and a support surface |
| 04/24/2008 | DE102006049585A1 Nail varnish useful for treating toenail and fingernail disorders comprises urea; fatty acids; allantoin, dexpanthenol, hyaluronic acid, penetration enhancer, antimicrobial agent, antipsoriatic agent and/or antieczema agent |
| 04/24/2008 | DE102006049520A1 Verfahren zur Herstellung von Pradofloxacin Process for preparing pradofloxacin |
| 04/24/2008 | CA2665538A1 Hiv integrase inhibitors |
| 04/24/2008 | CA2663885A1 Immunisation method against the 4 dengue serotypes |
| 04/23/2008 | EP1914313A1 Method for producing cercosporamide |
| 04/23/2008 | EP1914312A2 Virulence genes and proteins, and their use |
| 04/23/2008 | EP1914237A2 Phosphonate ester antiviral compounds |
| 04/23/2008 | EP1913956A1 Compositons and methods for stablizing biological molecules upon lyophilization |
| 04/23/2008 | EP1913951A1 Method for the extraction of polyphenols and uses thereof |
| 04/23/2008 | EP1913948A1 Re-epithelializing pharmaceutical compositions containing xanthan gum |
| 04/23/2008 | EP1913141A2 Sirna microbicides for preventing and treating viral diseases |
| 04/23/2008 | EP1913025A2 Anti-microbial agents that interact with the complement system |
| 04/23/2008 | EP1913019A2 Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
| 04/23/2008 | EP1913016A1 Macrocyclic peptides as hcv ns3 protease inhibitors |
| 04/23/2008 | EP1913015A1 Macrocyclic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1913014A1 Macrocyclic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1912999A1 Macrocyclic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1912997A1 Macrocylic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1912996A1 Macrocyclic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1912995A1 Macrocylic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1912980A2 Oxazolidinones bearing antimicrobial activity composition and methods of preparation |
| 04/23/2008 | EP1912948A1 Antibacterial quinoline derivatives |
| 04/23/2008 | EP1912935A2 Hiv reverse transcriptase inhibitors |
| 04/23/2008 | EP1912668A2 Il28 and il29 truncated cysteine mutants and antiviral methods of using same |
| 04/23/2008 | EP1912662A2 Peptide deformylase inhibitors |
| 04/23/2008 | EP1912649A2 Quinoline derivatives as antibacterial agents |
| 04/23/2008 | EP1912648A2 Quinoline derivatives as antibacterial agents |
| 04/23/2008 | EP1912647A2 Quinoline derivatives as antibacterical agents |
| 04/23/2008 | EP1912643A2 5-aza-7-deazapurine derivatives for treating infections with flaviviridae |
| 04/23/2008 | EP1723160A4 Toll-like receptor 2 (tlr-2) haplotypes predict outcome of patients |
| 04/23/2008 | EP1597263B1 Preparation of a trans-calanolide ketone intermediate and chiral separation of calanolide alcohols to give racemic calanolide a |
| 04/23/2008 | EP1434858B1 Method for the amplification of a poxvirus under serum free conditions |
| 04/23/2008 | EP1372712B1 Equine herpesvirus vaccine |
| 04/23/2008 | EP1333834B1 Antiinflammation agents |
| 04/23/2008 | EP1284993B1 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella paraperussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions |
| 04/23/2008 | EP1251871B1 Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and as adjuvants an immunogenic oligodeoxynucleotide and a polycationic polypeptide |
| 04/23/2008 | EP1238071B1 Uncharged antisense oligonucleotides targeted to bacterial 16s and 23s rrnas and their uses |
| 04/23/2008 | EP1216230B1 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/23/2008 | EP0804212B1 Nigella sativa as a medicinal treatment |
| 04/23/2008 | CN101166828A Enzymatic production of peracids using perhydrolytic enzymes |
| 04/23/2008 | CN101166762A Albumin-fused Kunitz domain peptides |
| 04/23/2008 | CN101166740A Imidazo (1,2-a) pyridine derivatives useful as peptide deformylase (PDF) inhibitors |
| 04/23/2008 | CN101166559A Immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
| 04/23/2008 | CN101165070A A series of fusion protein with dual biological activity and medical treatment thereof |
| 04/23/2008 | CN101164623A Compositions comprising viruses and methods for concentrating virus preparations |
| 04/23/2008 | CN101164615A BAFF, inhibitors thereof and their use in the modulation of B-cell response |
| 04/23/2008 | CN101164611A Traditional Chinese medicine for treating invasion of lung by cold type pertussis |
| 04/23/2008 | CN101164609A Method for preparing spraying agent for treating smelly feet and beriberi |
| 04/23/2008 | CN101164596A Traditional Chinese medicine for treating heat type cold measles |
| 04/23/2008 | CN101164582A Traditional Chinese medicine for treating infantile mycotic enteritis |
| 04/23/2008 | CN101164572A Orally-administered medicine for treating hepatitis B virus |
| 04/23/2008 | CN101164556A Musk ointment for treating osteopathy |
| 04/23/2008 | CN101164553A Application of jin mushroom polysaccharide germanium in preparing medicine for inhibiting H5N1 avian influenza virus |
| 04/23/2008 | CN101164550A Application of realgar microorganism leaching liquid in preparing antibiotic and antiviral medicine |
| 04/23/2008 | CN101164543A Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| 04/23/2008 | CN101164539A New use of staurosporine derivatives |
| 04/23/2008 | CN101164537A High-efficient oral silibinin sustained-release preparation and preparation method thereof |
| 04/23/2008 | CN100383164C Antiviral fusion protein and its coding gene and uses |
| 04/23/2008 | CN100383157C 3beta, 5 alpha, 6 beta, 11 beta tetrahydroxy cholestanol, and its preparing method and use |
| 04/23/2008 | CN100383149C New crystalline Idedate and its composition |
| 04/23/2008 | CN100383148C Nucleotide analog composition and synthesis method thereof |
| 04/23/2008 | CN100383140C Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 04/23/2008 | CN100382844C Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and use of anti-lymphotoxin ligand antibodies |
| 04/23/2008 | CN100382836C External use traditional Chinese medicinal preparation for treating ringworm of the nails |
| 04/23/2008 | CN100382835C Disinfectant liquid for treating hand/foot tinea |
| 04/23/2008 | CN100382821C Vitis botanical extractive, its preparation method and its novel usage as an antibacterials synergist |
| 04/23/2008 | CN100382805C Azithromycin enteric casing microsphere and its preparing process |
| 04/23/2008 | CN100382804C Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections |
| 04/23/2008 | CN100382801C Pharmaceutical use of alpha-(2,4-dichlorobenzyle)-1H-imidazole-1-ethanol for treating hepatitis |
| 04/23/2008 | CN100382800C Bifendate solid dispersible, and its preparing method and low-release preparation containing same |
| 04/23/2008 | CN100382799C Power for intravenous injection with liver-protecting action, and its preparation and quality control method |
| 04/23/2008 | CN100382795C Glycinamide derivative for inhibiting HIV replication |